Innovative Clinical Approach in Biosimilars

Clinical trials for biosimilars must exhibit practically identical security what's more, viability to the reference item, including consecutive PK/ PD and viability/security trials. Controllers expect PK/PD similarity information from a Phase I trial will bolster encourage viability/ wellbeing evaluations in crucial Phase III trials. Remain solitary Phase III investigations or joined Phase I/III outlines without supporting PK information are probably not going to be acknowledged. Clinical similarity prerequisites may fluctuate on a case-by-case premise subject to a risk based approach. Three-arm Phase I trials are progressively being used to show equivalence between the biosimilars and two authorized adaptations of a similar reference item that may exist in various markets, allowing developers to proceed with pivotal trials using a single version of the reference product.

    Related Conference of Innovative Clinical Approach in Biosimilars

    July 25-26, 2024

    34th Annual European Pharma Congress

    Frankfurt, Germany
    August 06-07, 2024

    27th World Congress on Nursing, Pharmacology and Healthcare

    Aix-en-Provence, France
    August 28-29, 2024

    4th International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    October 31-01, 2024

    37th World Congress on Pharmacology

    Amsterdam, Netherlands
    November 26-27, 2024

    3rd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2024

    3rd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 28-29, 2024

    12th International Conference on Clinical Trials

    Vancouver, Canada
    November 28-29, 2024

    39th World Congress on Pharmacology and Therapeutics

    Paris, France
    December 05-06, 2024

    17th World Drug Delivery Summit

    Dubai, UAE
    March 13-14, 2025

    8th International on Pharmacy and Pharmaceutical Conference

    Prague, Czech Republic
    April 14-15, 2025

    18th European Biosimilars Congress

    Aix-en-Provence, France

    Innovative Clinical Approach in Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in